Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nylestriol for Perioperative Management of Pelvic Organ Prolapse in Postmenopausal Women
ChiCTR2600119586Phase 4Not yet recruiting
- Sponsor
- The Second Xiangya Hospital
- Start
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of nilestriol in pelvic organ prolapse (POP) and vaginal atrophy (2 arms), sponsored by The Second Xiangya Hospital. Primary endpoints: Intraoperative bleeding volume, Operation time and 1 more. Planned start Feb 2026; status: not yet recruiting.
02
Drugs
nilestriol
03
Conditions
pelvic organ prolapse (POP)vaginal atrophy
Beyond the preview
Go deeper on ChiCTR2600119586.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600119586.